Entity
  • DiaDeep

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,534 1,534
  • Activities

  • Technologies

  • Entity types

  • Location

    Lyon, France

    Lyon

    France

  • Employees

    Scale: 11-50

    Estimated: 10

  • Engaged corporates

    29
    5 10
  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    Every patient matters, every decision counts !

    Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence?
    This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives.
    To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications.
    These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast cancer, melanoma, and more.
    With our unique holistic approach, we provide real-time insights that empower pathologists and oncologists, facilitating and securing their decision-making processes.

    Biotech, Digital Pathology, and Artificial Intelligence

  • Original language

    Every patient matters, every decision counts !

    Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence?
    This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives.
    To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications.
    These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast cancer, melanoma, and more.
    With our unique holistic approach, we provide real-time insights that empower pathologists and oncologists, facilitating and securing their decision-making processes.

Corporate interactions BETA
Corporate TypeTweets Articles
Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

31 May 2023


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

31 May 2023


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care
Other

31 May 2023


Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

31 May 2023


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

18 Sep 2024


Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care
Other

31 May 2023


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

30 Sep 2024


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

24 Sep 2023


La French Tech Saint-Etienne Lyon
La French Tech Saint-Etienne Lyon
French Tech, IT Services and IT Consulting
La French Tech Saint-Etienne Lyon
French Tech, IT Services and IT Consulting
Other

18 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics